Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.00 $15.18 Friday, 10th May 2024 ASMB stock ended at $13.40. This is 3.00% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.51% from a day low at $12.85 to a day high of $13.43.
90 days $11.01 $15.18
52 weeks $0.641 $15.18

Historical Assembly Biosciences prices

Date Open High Low Close Volume
May 10, 2024 $12.97 $13.43 $12.85 $13.40 16 024
May 09, 2024 $13.20 $13.99 $12.80 $13.01 75 460
May 08, 2024 $12.53 $13.05 $12.51 $12.85 13 845
May 07, 2024 $13.26 $13.46 $12.60 $12.62 33 107
May 06, 2024 $13.03 $13.48 $12.85 $12.85 19 515
May 03, 2024 $13.30 $13.30 $12.90 $13.15 4 556
May 02, 2024 $13.28 $13.28 $12.81 $12.81 20 718
May 01, 2024 $13.04 $13.44 $12.75 $13.27 12 036
Apr 30, 2024 $12.83 $12.88 $12.18 $12.47 11 633
Apr 29, 2024 $12.83 $13.50 $12.52 $12.90 10 133
Apr 26, 2024 $13.40 $13.43 $12.00 $12.65 29 386
Apr 25, 2024 $12.98 $13.38 $12.98 $13.36 6 103
Apr 24, 2024 $13.40 $13.48 $13.05 $13.48 5 632
Apr 23, 2024 $13.22 $13.27 $13.00 $13.27 13 829
Apr 22, 2024 $13.66 $13.66 $13.14 $13.22 7 204
Apr 19, 2024 $13.69 $13.90 $13.24 $13.41 11 270
Apr 18, 2024 $12.95 $13.33 $12.40 $13.33 16 689
Apr 17, 2024 $14.80 $14.80 $12.55 $12.92 26 429
Apr 16, 2024 $14.65 $14.96 $14.35 $14.52 7 400
Apr 15, 2024 $14.66 $15.18 $14.55 $14.93 17 358
Apr 12, 2024 $14.97 $15.00 $14.59 $14.65 19 380
Apr 11, 2024 $14.35 $15.07 $14.35 $15.06 13 918
Apr 10, 2024 $14.78 $14.99 $14.51 $14.68 8 353
Apr 09, 2024 $14.42 $14.99 $14.20 $14.85 26 414
Apr 08, 2024 $14.04 $14.70 $14.04 $14.40 17 966
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT